Showing results (21-30 of 136) with videos related to
Sort By:
Pageof 14
Oncoimmunology|April 11, 2018
Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinomaKyu Seo Kim, Rishi R Sekar, Dattatraya Patil, et al.Journal of Medical Economics|July 15, 2025
Healthcare resource utilization and costs among patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide in the United States (2019-2023)Mehmet A Bilen, Benjamin Lowentritt, Sabree Burbage, et al.European Urology|August 19, 2025
The Role of Liquid Biopsy in the Management of Patients with Genitourinary MalignanciesBenjamin L Maughan, Lars Dyrskjøt, Petros Grivas, et al.Advances in Therapy|June 17, 2025
Comparison of Real-World Outcomes between Patients with BRCA1/2-Positive and Homologous Recombination Repair-Negative Metastatic Castration-Sensitive Prostate CancerMehmet A Bilen, Sabree Burbage, Carmine Rossi, et al.European Journal of Cancer (Oxford, England : 1990)|November 1, 2018
Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysisMatthew T Campbell, Mehmet A Bilen, Amishi Y Shah, et al.Urologic Oncology|October 13, 2018
The addition of chemotherapy in the definitive management of high risk prostate cancerMatthew J Ferris, Yuan Liu, Jingning Ao, et al.American Journal of Nuclear Medicine and Molecular Imaging|July 8, 2021
Exploratory study of 18F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancerAkinyemi A Akintayo, Mehmet A Bilen, Olayinka A Abiodun-Ojo, et al.Journal of Cell Science|November 1, 2015
Cadherin-11 endocytosis through binding to clathrin promotes cadherin-11-mediated migration in prostate cancer cellsRobert L Satcher, Tianhong Pan, Mehmet A Bilen, et al.Urology|April 16, 2020
Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell CarcinomaDattatraya Patil, Thien-Linh Le, Kc Biebighauser Bens, et al.JCI Insight|November 24, 2025
Targeting p300 and CBP abolishes HOXB13-loss-induced lipogenesis and tumor metastasisXiaodong Lu, Liu Peng, Qi Chu, et al.Pageof 14